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Introduction
Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by 
a novel coronavirus. The outbreak started in December 2019, in Wuhan, China. 
The genetic sequencing of the virus suggests that it is a beta-coronavirus closely 
related to the Severe Acute Respiratory Syndrome (SARS) virus.[1] Since then, 
the virus has been spreading rapidly across the world. By March 11, 2020, the 
virus had reached more than 100 countries, which forced the World Health 
Organization (WHO) to officially declare COVID-19 a pandemic.[2] As of April 
15, there were more than 1.9 million confirmed cases and more than 123,000 
deaths reported worldwide. On that date, the USA had 578,268 confirmed cases 
and 23,476 deaths while South Korea had 10,591 confirmed cases and 225 deaths 
reported.[3]
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Abstract
Background: Coronavirus disease 2019 (COVID-19) is a respiratory tract 
infection cause by a novel coronavirus. The outbreak started in Wuhan, China, 
in December 2019 and began to spread rapidly to more than 100 countries 
and territories. By March 11, the World Health Organization (WHO) had 
officially declared COVID-19 a pandemic. 
Objective: To review the effectiveness of American and South Korean testing 
approaches of the COVID-19 plan. 
Method: Daily reports of the USA’s and South Korea’s COVID-19 cases from 
February 15 to April 15, 2020 were examined. The outcome of interest was 
total number of cases and tests per one million population, daily cases reported, 
and percentage of recovered cases and case fatality rate (CFR). Data were 
analysed using Microsoft excel sheet and tables and figures generated. 
Result: As of April 15 2020, USA’s and South Korea’s number of cases per 
million population are 1,946 and 207 cases, respectively. The daily American 
confirmed cases of COVID-19 had been increasing steadily from February 15 
to April 15, 2020. Our study shows that South Korea and the USA recovered 
cases were 97% and 63%, respectively, while the case fatality rate in the USA 
was 37% and 3% in South Korea. 
Conclusion: Despite its advanced health care systems, the USA is currently 
experiencing a devastating virus that has claimed many lives. This is because 
the USA has approached the outbreak differently. The evidence suggests that 
South Korea’s aggressive testing has effectively managed to control the spread 
of COVID-19, it increases the recovered rate and reduced the CFR more than 
the USA’s conservative testing approach. Although the South Korea health 
care system is not comparable to those in the developing countries, it worth 
mentioning that its plan would suit well these countries and should be adopted. 
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Recent observation studies have shown that while the 
majority of COVID-19 patients have mild symptoms 
(81%) that don’t require hospital admission, some 
developed severe symptoms that required hospitalization 
(19%). Out of those admitted, 14% were seriously ill and 
required oxygen therapy; 5% of the critically ill patients 
needed admission to an intensive care unit. Of those sick 
critically, most required mechanically assisted ventilation. 
Furthermore, those with mild symptoms did not require 
hospital admission unless they developed breathing 
difficulties or conditions that urgently need medical 
attention.[4, 5] 
For the purpose of this review, the USA approach is 
defined as the conservative testing approach which restricts 
the testing of coronavirus to those who meet the Centers 
for Disease Control and Prevention (CDC) guidelines, 
namely seriously ill patients that require hospitalization; 
adults with underlying chronic medical conditions such 
as cardiovascular, respiratory disease,  and asthma, and 
immunocompromised patients. The Korean approach 
is defined as the aggressive testing approach where every 
suspected case of coronavirus regardless of severity of 
disease or underlying medical conditions is tested.  
Most studies published since the onset of this outbreak 
focused mainly on the characteristics, pathophysiology, 
mode of transmission, and management of COVID-19. 
Some focused on public health measures such as social 
distancing, self-quarantine, and containment. However, 
none have reviewed the effectiveness of South Korea’s 
aggressive testing and USA’s conservative testing. The next 
wave of the outbreak is already happening in developing 
countries where the health care systems are fragile. Hence, 
it appears that an outbreak that has overwhelmed the 
best health care systems in developed countries such as 
the USA, United Kingdom, Italy, Spain, and France, 
will have devastating effects on developing nations. 
Therefore, learning from the experience of other countries 
that flattened their disease curves early is essential. This 
study aims to review the effectiveness of South Korea’s 
aggressive and the USA’s conservative testing approach 
and recommend the best approach appropriate for 
adoption in developing countries.
Ethical consideration 
Our review is a secondary data analysis from the WHO 
daily reports on the COVID-19 pandemic. The datasets 
used for this review are publicly available.
Method
We reviewed the World Health Organization’s COVID-19 
daily reports from the USA and South Korea published 
online from February 15 to April 15. Our review focused 
mainly on the total (number of cases and tests) per 1 
million population, daily cases reported, the percentage 
Figure 4. Percentage recovery rate and case fatality rate in USA 
and South Korea [6,9]
Figure 1. USA and South Korea. Total number of cases and tests 
per 1 million population [6,9]
Figure 2. United States of America daily cases of Coronavirus [9]
 Figure 3. South Korea daily cases of Coronavirus [6]
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of recovered cases and the case fatality rate (CFR). The 
percentage of recovered cases and CFR were computed 
by dividing the number of recovered cases by the total 
number of recovered cases and deaths respectively, by the 
total number of closed cases. Data were analysed using 
Microsoft excel sheet and tables to generate figures. 
Results
Figure 1 shows the total number of cases and tests per 
one million of the population; Figures 2 and 3 graphs the 
number of USA and South Korean daily confirmed cases 
from 10 March until 15 April, and Figure 4 compares the 
percentage recovery rate and case fatality rate in the two 
countries.
Discussion
As of April 15, 2020, in USA and South Korea, the 
number of cases per million population was 1,946 and 
207 cases, respectively (see Figure 1). Although the health 
care institutions and population age distribution in both 
countries are comparable, the number of USA cases per 
million are more than nine times those of South Korea. 
South Korea and the USA confirmed their first case on 
January 19 and 20, respectively, so the only possible 
differences between the two countries are the way each 
approached the outbreak. For example, the USA’s 
efforts have been significantly affected by a shortage of 
COVID-19 testing kits. These shortages have forced the 
United States health authorities to restrict the COVID-19 
testing for seriously ill patients that require admission 
and patients with underline chronic conditions, namely 
diabetes, cardiovascular diseases, hypertension, asthma, 
and respiratory disease, as well as immunocompromised 
patients. 
By adopting this conservative testing, the USA has focused 
mainly on 19% of patients who were seriously ill and 
needed hospital admission. Therefore, there is a possibility 
that 81% of asymptomatic and mild symptom patients 
have been spreading the infection in the community, 
especially before introducing public health measures 
of social distancing, prohibiting public gathering, and 
total lockdown in some cities. This conservative testing 
approach left many mild and moderately ill people 
spreading the infection more rapidly. These may explain 
the reason behind steady increases in many new cases in 
the USA since March (see Figure 2) or they had not taken 
the public health guideline seriously, especially when 
patients are denied a testing opportunity.[5] Furthermore, 
they may assume they were not infected, and the result is 
spreading of the infection more rapidly.  
In contrast, South Korea has been more successful 
than the USA in controlling the spread of COVID-19 
because of experience from the prior outbreaks, such 
as the 2015 Middle Eastern Respiratory Syndrome 
(MERS) outbreak[7] and its aggressive testing approach. 
This approach provides a testing opportunity for every 
individual regardless of their underline medical condition. 
Besides, South Korea has responded rapidly by inventing 
and implementing the idea of a drive-through testing 
centre. This brilliant invention of the drive-through free 
testing makes the testing process faster, keeps clinicians 
and patients safe, removes ten minutes from cleaning 
rooms, and cut the length of the test in half.[7] Also, South 
Korea has managed to flatten its curve rapidly because 
its approach has not left mild and moderate ill patients 
without testing; therefore, effectively slowing the spread 
of the infection within communities. 
The daily USA’s confirmed cases of COVID-19 had 
increased steadily from February 15 to April 15, 2020 
(see Figure 2). Experts believe that the numbers do not 
accurately reflect the sharp picture of the epidemic. This is 
because the USA is still unable to produce enough testing 
kits to meet the urgent surge in demand for testing as the 
number of infected people continue to increase. Without 
enough testing available, many patients have to wait a long 
time before being scheduled for testing. The availability of 
tests is a significant factor in the control of the outbreak 
since isolation, tracing of contacts, and quarantine of 
suspected cases depends on how robust and fast the testing 
process is. Even though South Korea has confirmed its 
first cases one day ahead of the USA, it flattened its curved 
as early as March 11, 2020, leaving the USA struggling 
with the spread of infection (see Figures 2 and 3).
Although the recovered cases and death toll depend mainly 
on the quality of health care services, number of hospital 
and ICU beds, and trained medical personnel, still the 
recovered rates and CFR are in favour of South Korean 
aggressive approach. For example, our review shows that 
recovered cases reported in South Korea and the USA 
were 97% and 63%, respectively. While the CFR was 
37% in the USA and 3% in South Korea (Figure 4), even 
though estimating the case fatality rate at the beginning of 
the outbreak overestimate the case fatality, it can give us 
an overview of the clear picture that may be looming.[8]
Limitations
The reliance on population data limited our review. It 
may lead to a deficiency in collecting some key data about 
the demographic distribution of COVID-19 patients as 
well as any underlined medical conditions. Also, it is very 
hard to compare the CFR and recovery rates  of different 
countries due to different settings.  
Conclusion
The conservative testing approach in the USA has led to 
a devastating pandemic that has claimed thousands of 
lives. The evidence suggests that South Korea’s aggressive 
testing has effectively managed to control the spread of 
COVID-19, it increases the recovered rate and reduces the 
CFR more than the USA approach. With no capacity for 
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case management of severe COVID-19 illness, developing 
countries should focus on testing of all suspected cases and 
tracing the contacts to limit the spread of the disease.
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